stage IIA cervical cancer
Showing 1 - 25 of >10,000
Human Papilloma Virus Circulating Tumor DNA in Cervical Cancer
Recruiting
- Cervical Adenosquamous Carcinoma
- +26 more
- Biospecimen Collection
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 4, 2023
Patients With Neuroendocrine Cancer of the Cervix
Recruiting
- Cervical Large Cell Neuroendocrine Carcinoma
- +21 more
- Follow-Up
- Medical Chart Review
-
Houston, TexasM D Anderson Cancer Center
Dec 5, 2022
Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma, Cervical Squamous Cell Carcinoma, Not Otherwise Specified Trial in
Recruiting
- Cervical Adenocarcinoma
- +11 more
- Media Intervention
- +4 more
-
Houston, TexasM D Anderson Cancer Center
Jun 15, 2022
Patient-Informed Educational Intervention for Improvement of
Withdrawn
- Stage IB Cervical Cancer FIGO 2018
- +15 more
- Educational Intervention
- Survey Administration
- (no location specified)
Mar 25, 2022
Localized Prostate Carcinoma, Locally Advanced Cervical Carcinoma, Locally Advanced Rectal Carcinoma Trial in Duarte (procedure,
Recruiting
- Localized Prostate Carcinoma
- +17 more
- Biospecimen Collection
- +4 more
-
Duarte, CaliforniaCity of Hope Medical Center
Feb 1, 2023
Locally Advanced Cervical Squamous Cell Carcinoma, Not Otherwise Specified, Stage IB3 Cervical Cancer FIGO 2018, Stage II
Recruiting
- Locally Advanced Cervical Squamous Cell Carcinoma, Not Otherwise Specified
- +13 more
- Cisplatin
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Mar 31, 2022
MRI and PET Imaging in Predicting Treatment Response in Stage
Active, not recruiting
- Cervical Adenocarcinoma
- +12 more
- Computed Tomography
- +5 more
-
Miami, Florida
- +5 more
Oct 4, 2022
Radiomics-based Malnutrition for Cervical Cancer.
Not yet recruiting
- Cervical Cancer
- Malnutrition
- There are no interventions.
-
Hangzhou, Zhejiang, ChinaZhejiang Provincial People's Hospital
Jan 24, 2023
Malignant Female Reproductive System Tumor, Stage I Cervical Cancer AJCC v8, Stage I Uterine Corpus Cancer AJCC v8 Trial in
Recruiting
- Malignant Female Reproductive System Neoplasm
- +44 more
- Counseling
- +2 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Feb 25, 2022
Among Reproductive Age Gynecological and Breast Cancer
Recruiting
- Anatomic Stage I Breast Cancer AJCC v8
- +29 more
- Healthcare Activity
- Survey Administration
-
Houston, TexasM D Anderson Cancer Center
Nov 2, 2022
Remote Telemonitoring of Patient-Generated Physiologic Health
Recruiting
- Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8
- +171 more
- Patient Monitoring
- Questionnaire Administration
-
Duarte, CaliforniaCity of Hope Medical Center
Aug 15, 2022
Uterine Cervical Tumors, Chemoradiotherapy, Angiogenesis Trial in Wuhan (Hydrochloride anlotinib, cis Platinum/carboplatin,
Recruiting
- Uterine Cervical Neoplasms
- +2 more
- Hydrochloride anlotinib
- +2 more
-
Wuhan, Hubei, ChinaZhongnan Hospital of Wuhan University
May 17, 2022
Lymphedema, Stage 0 Cervical Cancer, Stage 0 Uterine Corpus Cancer Trial in Philadelphia (Management of Therapy Complications,
Terminated
- Lymphedema
- +18 more
- Management of Therapy Complications
- Quality-of-Life Assessment
-
Philadelphia, PennsylvaniaGynecologic Oncology Group
Jun 11, 2021
Cervical Cancer Trial in Shanghai (Total Laparoscopic or Robotic Radical Hysterectomy, Total Abdominal Radical Hysterectomy)
Recruiting
- Cervical Cancer
- Total Laparoscopic or Robotic Radical Hysterectomy
- Total Abdominal Radical Hysterectomy
-
Shanghai, Shanghai, ChinaThe Obstetrics and Gynecology Hospital of Fudan University
Nov 2, 2021
Cervical Cancer Trial in Shanghai (Total Laparoscopic or Robotic Radical Hysterectomy, Total Abdominal Radical Hysterectomy)
Recruiting
- Cervical Cancer
- Total Laparoscopic or Robotic Radical Hysterectomy
- Total Abdominal Radical Hysterectomy
-
Shanghai, Shanghai, ChinaThe Obstetrics and Gynecology Hospital of Fudan University
Oct 25, 2021
Uterine Cervical Tumors, Sintilimab Trial in Xuzhou (Sintilimab, Cisplatin, External Beam Radiotherapy (EBRT))
Recruiting
- Uterine Cervical Neoplasms
- Sintilimab
- Sintilimab
- +3 more
-
Xuzhou, Jiangsu, ChinaThe Affiliated Hospital of Xuzhou Medical University
Dec 24, 2021
After Whole Vaccination Shcedule With Recombination Quadrivalent
Not yet recruiting
- HPV Infections
- +6 more
- (no location specified)
May 7, 2022
Cervical Esophagus Adenocarcinoma, Clinical Stage II Esophageal Adenocarcinoma AJCC v8, Clinical Stage IIA Esophageal
Recruiting
- Cervical Esophagus Adenocarcinoma
- +12 more
- Capecitabine
- +8 more
-
Houston, TexasM D Anderson Cancer Center
Dec 31, 2022
Endometrial Carcinoma, Stage 0 Fallopian Tube Cancer AJCC v7, Stage I Fallopian Tube Cancer AJCC v6 and v7 Trial in New
Withdrawn
- Endometrial Carcinoma
- +55 more
- Internet-Based Intervention
- +3 more
-
New Brunswick, New JerseyRutgers Cancer Institute of New Jersey
Apr 16, 2021
Cervical Adenocarcinoma, Cervical Adenocarcinoma In Situ, Cervical Intraepithelial Neoplasia Trial in Houston (Biospecimen
Recruiting
- Cervical Adenocarcinoma
- +54 more
- Biospecimen Collection
- Laboratory Biomarker Analysis
-
Houston, Texas
- +1 more
Nov 30, 2020
HPV Infections, Cervical Cancer Stage IIa, Vaginal Cancer Trial in Mianyang (2-doses Group among 9-14 years, 3-doses Group among
Recruiting
- HPV Infections
- +6 more
- 2-doses Group among 9-14 years
- +2 more
-
Mianyang, Sichuan, ChinaCenter for Disease Control and Prevention
Feb 23, 2022
Cervical Cancer Trial in Amsterdam (Anti-PD-1 antibody balstilimab)
Not yet recruiting
- Cervical Cancer
- Anti-PD-1 antibody balstilimab
-
Amsterdam, NetherlandsAmsterdam UMC
Oct 17, 2023
Magnetic Resonance Fingerprinting for Preoperative Evaluation of
Recruiting
- Cervical Cancer
-
Roma, ItalyFondazione Policlinico Universitaro "A. Gemelli" IRCCS
Mar 29, 2023
NSCLC, Neoadjuvant Therapy, Radiotherapy Trial in Yangzhou (drug, radiation, other)
Recruiting
- Non-small Cell Lung Cancer
- +3 more
- Toripalimab
- +2 more
-
Yangzhou, Jiangsu, ChinaPeople's hospital of northern jiangsu
Sep 26, 2023